92 results for “Queen”

Set a search alert

AuthorWiroje Kaewruang1 article

AuthorThanes Chantes1 article

AuthorSuttisan Pimpasalee1 article

AuthorV. Eranki1 article

AuthorG. Morrison1 article

AuthorUmar Iqbal1 article

AuthorMahmoud ElGizawy1 article

AuthorJacques Georgy1 article

AuthorT.R.A. Magee1 article

Research ArticleOpen accessIn the abstractRivaroxaban and its Effect on International Normalised Ratio-A Prospective Study of 28 Hip and Knee Arthroplasty PatientsV. Eranki, A. Pillai, G. Morrison, Cheng Hong YeoProblem statement: Rivaroxaban is an orally active, competitively reversible antagonist of activated factor Xa. The purpose of this study is to comment on Riveroxaban’s effect on INR. Approach: At the Queen Elizabeth Hospital, all patients undergoing elective anthroplasty were anticoagulated with 10mg of Rivaroxaban. All patients had INR measurements for 3 days post operatively. Further 16 patients had weekly INR … …Current Research in Medicine, Vol. 3, Issue 2 · 12 Jul 2012 · 21,050 accessesView PDF Cite